Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.
scientific article
Author/s
author: Athanasios Dimopoulos, Judith Trotman, Constantine S. Tam, Albert Oriol, Ramón García-Sanz, Jorge Castillo, Argiris Symeonidis, Efstathios Kastritis, Veronique Leblond, Marie-Christine Kyrtsonis, Alessandra Tedeschi, Carlos Fernández de Larrea, Steven P. Treon, Christian Buske, Leonard T Heffner, Olivier Tournilhac, Chaim Shustik, Elizabeth Bilotti
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.